BIOETHICS - BIOethics Exploring Trajectories of Health Innovations Challenging Society

  • Bravo E, Calzolari A, De Castro P, Mabile L, Napolitani F, Rossi AM, Cambon-Thomsen A, Developing a guideline for a standardized citation of bioresources injournal articles (CoBRA). BMC Medicine.  2015. 13:33. doi: 10.1186/s12916-015-0266-y. abstract
  • Mahalatchimy A, Rial-Sebbag E, Duguet AM, Taboulet F, Cambon-Thomsen A.  The impact of European embryonic stem cell patent decisions on research strategies. Nat Biotech, 2015. 33: 41-43 accès
  • Mahalatchimy A, Rial-Sebbag E, Duguet AM, Cambon-Thomsen A, Taboulet F. Exclusion of patentability of Embryonic stem cells in Europe:another restriction by the European Patent Office. European Intellectual Property Review. 2015. 37(1): 5- 28. accès
  • Fransson MN, Rial-Sebbag E, Brochhausen M, Litton JE. Toward a common language for biobanking. Eur J Hum Genet. 2015. 23(1):22-8. doi: 10.1038/ejhg.2014.45. Epub2014 Apr 9. abstract
  • Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Duijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W. Beyond Public Genomics: proposalsfrom an International Working Group. Eur J Public Health. 2014. 24(6):876-8. accès

  • Cambon-Thomsen A. [Actors and tools of predictive genetics: ethics at the heart of governance]. J Int Bioethique. 2014. 25(2):159-68. French abstract

  • Scelo G, Riazalhosseini Y, Greger L, Letourneau L, Gonzàlez-PortaM, Wozniak M B, Bourgey M, Harnden P, Egevad L, Jackson S M, KarimzadehM, Arseneault M, Lepage P, How-Kit A, Daunay A, Renault V, Blanché H,Tubacher E, Sehmoun J, Viksna J, Celms E, Opmanis M, Zarins A, Vasudev NS, Seywright M, Abedi-Ardekani B, Carreira C, Selby P J, Cartledge J J,Byrnes G, Zavadil J, Su J, Holcatova I, Brisuda A, Zaridze D, Moukeria A,Foretova L, Navratilova M, Mates D, Jinga V, Artemov A, Nedoluzhko A,Mazur A, Rastorguev S, Boulygina E, Heath S, Gut M, Bihoreau M T, LechnerD, Foglio M, Gut I G, Skryabin K, Prokhortchouk E, Cambon-Thomsen A, Rung J, Bourque G, Brennan P, Tost J, Banks R E, Brazma A, GLathrop M. Variation in genomic landscape of clear cell renal cellcarcinoma across Europe. Nat Commun. 2014. 29;5:5135 abstract

  • Rial-Sebbag E, Blasimme A. The European Court of Human Rights' ruling on unproven stem cell therapies: a missed opportunity?   Stem Cells Dev. 2014. suppl 1:39-43. doi:10.1089/scd.2014.0361. abstract

  • Rial-Sebbag E. [Personalized medicine, privatized medicine? legal and public health stakes]. Med Sci (Paris).2014. Spec n°2:36-40. doi:10.1051/medsci/201430s208.  French. abstract

  • Chabannon C, Sabatier F, Rial-Sebbag E, Calmels B, Veran J, Magalon G, Lemarie C, Mahalatchimy A. [Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products]. Med Sci (Paris). 2014. 30(5):576-83. doi: 10.1051/medsci/20143005022. French. abstract
  • Blasimme A, Rial-Sebbag E. Regulation of cell-based therapies in Europe: current challenges and emerging issues. Stem Cells Dev. 2013. 22 Suppl 1:14-9. doi:10.1089/scd.2013.0352. abstract
  • Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine. 2014. 81(3):228-34. doi: 10.1016/j.jbspin.2013.10.002. abstract
  • Meslin EM, Blasimme A, Cambon-Thomsen A. Mapping the translational science policy 'valley of death. Clin Transl Med. 2013.2(1):14. doi: 10.1186/2001-1326-2-14. abstract

  • Anastasova V, Mahalatchimy A, Rial-Sebbag E, Antó Boque JM, Keil T, Sunyer J, Bousquet J, Cambon-Thomsen A. Communication of results and disclosure of incidental findings in longitudinal paediatric research. Pediatr Allergy Immunol 2013.24(4): 389-94. abstract
  • Ducournau P, Gourraud PA, Rial-Sebbag E, Cambon-Thomsen A, Bulle A. Direct-to-consumer health genetic testing services: What commercial strategies for which socio-ethical issues ? Health Sociology Review. 2013.22(1):75-87. abstract
  • Mabile L, Dalgleish R, Thorisson GA, Deschênes M, Hewitt R, Carpenter J, Bravo E, Filocamo M, Gourraud PA, Harris JR, Hofman P, Kauffmann F, Muñoz-Fernàndez MA, Pasterk M, Cambon-Thomsen A. Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience. 2013.2(1):7. doi: 10.1186/2047-217X-2-7. abstract
  • Howard HC, Swinnen E, Douw K, Vondeling H, Cassiman JJ, Cambon-Thomsen A, Borry P. The ethical introduction of genome-based information and technologies into public health. Public Health Genomics. 2013.16(3):100-9.  doi: 10.1159/000346474. abstract

Publications antérieures Lire